期刊文献+

Syntheses and Crystal Structures of Two Novel Spiro Compounds Containing 1,5-Dioxaspiro[5.5]undecane-2,4-dione 被引量:3

Syntheses and Crystal Structures of Two Novel Spiro Compounds Containing 1,5-Dioxaspiro[5.5]undecane-2,4-dione
下载PDF
导出
摘要 Two novel spiro compounds,3-benzylidene-1,5-dioxaspiro[5.5]undecane-2,4-dione 1 and 3-(2-fluorobenzylidene)-1,5-dioxaspiro[5.5]undecane-2,4-dione 2,have been synthesized and characterized by X-ray single-crystal diffraction,IR and elemental analysis.Compound 1 belongs to the monoclinic system,space group P21/n with a=12.326(3),b=5.6420(11),c=20.089(4),β= 101.79(3)o,C16H16O4,Mr= 272.29,V=1367.7(5)3,Z=4,Dc=1.322g/cm3,F(000)=576,μ(MoKa)=0.095 mm-1,the final R=0.0420 and wR=0.1159.Compound 2 is of monoclinic system,space group P21/n with a=12.283(3),b=5.6367(11),c=20.055(4),β=102.00(3)o,C16H15FO4,Mr=290.28,V=1358.2(5)3,Z=4,Dc=1.420 g/cm3,F(000)=608,μ(MoKa)=0.110 mm-1,the final R=0.0353 and wR=0.0860. Two novel spiro compounds,3-benzylidene-1,5-dioxaspiro[5.5]undecane-2,4-dione 1 and 3-(2-fluorobenzylidene)-1,5-dioxaspiro[5.5]undecane-2,4-dione 2,have been synthesized and characterized by X-ray single-crystal diffraction,IR and elemental analysis.Compound 1 belongs to the monoclinic system,space group P21/n with a=12.326(3),b=5.6420(11),c=20.089(4),β= 101.79(3)o,C16H16O4,Mr= 272.29,V=1367.7(5)3,Z=4,Dc=1.322g/cm3,F(000)=576,μ(MoKa)=0.095 mm-1,the final R=0.0420 and wR=0.1159.Compound 2 is of monoclinic system,space group P21/n with a=12.283(3),b=5.6367(11),c=20.055(4),β=102.00(3)o,C16H15FO4,Mr=290.28,V=1358.2(5)3,Z=4,Dc=1.420 g/cm3,F(000)=608,μ(MoKa)=0.110 mm-1,the final R=0.0353 and wR=0.0860.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2010年第5期696-699,共4页 结构化学(英文)
基金 supported by the Natural Science Foundation of Shandong Province (No. Y2008B29)
关键词 synthesis crystal structure 1 5-dioxaspiro[5.5]undecane-2 4-dione spiro compounds synthesis, crystal structure, 1,5-dioxaspiro[5.5]undecane-2,4-dione, spiro compounds
  • 相关文献

参考文献20

  • 1Lian, Y.; Guo, J. J.; Liu, X. M,; Wei, R. B. Chem. Res. Chinese University 2008, 24, 441-444.
  • 2Kongsacrcc, P.; Prabpai, S.; Sriubolmas, N.; Vongvcin, C.; Wiyakrutta, S. J. Nat. Prod. 2003, 66, 709-711.
  • 3Ghosh, A.; Bischoff, A.; Cappiello. Eur.J. Org. Chem. 2003, 5, 821-823.
  • 4Oikawa, T.; Takcuchi, T. AnticancerRes. 1997, 17, 1881-1886.
  • 5Yao, M. L.; Deng, M. Z. J.. Org. Chem. 2000, 65, 5034-5036.
  • 6Berkovic, G.; Krongauz, V.; Weiss, V. Chem. Rev. 2000, 100, 1741-1753.
  • 7Kikuchi, H.; Miyagawa, Y.; Sahashi, Y. J. Org. Chem. 2004, 69, 352-356.
  • 8Pmdhan, R.; Patra, M.; Behem, A. K.; Mishra, B. K.; Behem, R. K. Tetrahedron 2006, 62, 779-828.
  • 9Jiang, Y.; Xue, S.; Li, Z.; Deng, J.; Mi, A.; Chan, A. S. C. Tetrahedron 1998, 9, 3185--3189.
  • 10W-i, R. B,; Liu, Y.; Guo, J. J.; Liu, B.; Zhang, D. W.J. Org. Chem. 2008, 28, 90-397.

同被引文献15

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部